MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to ...

Find and compare the best penny stocks under $2 in real time. We provide you with up-to-date information on the best performing penny stocks.

Gold Eagle provides the latest gold articles, technical analysis, market news, the current price of gold and precious metal charts for investors.